mixed- tissue tumors chemotherapy carcinoma invasive dedifferentiation anaplasia carcinogens microscopic description of tumors mutation genetic screening antibiotics modality gray apoptosis external beam irradiation irradiation encapsulated malignant tumor differentiation linear accelerator fractionation DNA immunotheraphy morbidity alkylating agents infiltrative molecularly targeted therapy mitosis fields gross description of tumors adjuvant chemotherapy brachytherapy metastasis electron beams grading of tumors mesenchymal mucinous benign tumor antimitotics combination chemotheraphy mixed- tissue tumors chemotherapy carcinoma invasive dedifferentiation anaplasia carcinogens microscopic description of tumors mutation genetic screening antibiotics modality gray apoptosis external beam irradiation irradiation encapsulated malignant tumor differentiation linear accelerator fractionation DNA immunotheraphy morbidity alkylating agents infiltrative molecularly targeted therapy mitosis fields gross description of tumors adjuvant chemotherapy brachytherapy metastasis electron beams grading of tumors mesenchymal mucinous benign tumor antimitotics combination chemotheraphy
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
mixed-tissue tumors
chemotherapy
carcinoma
invasive
dedifferentiation
anaplasia
carcinogens
microscopic description of tumors
mutation
genetic screening
antibiotics
modality
gray
apoptosis
external beam irradiation
irradiation
encapsulated
malignant tumor
differentiation
linear accelerator
fractionation
DNA
immunotheraphy
morbidity
alkylating agents
infiltrative
molecularly targeted therapy
mitosis
fields
gross description of tumors
adjuvant chemotherapy
brachytherapy
metastasis
electron beams
grading of tumors
mesenchymal
mucinous
benign tumor
antimitotics
combination chemotheraphy